Document ID: FDA-2023-N-2850-0002
Agency: fda
Document Type: Notice
Title: Prescription Drug User Fee Rates for Fiscal Year 2024; Correction
Posted Date: 2023-08-03T04:00Z

[Federal Register Volume 88, Number 148 (Thursday, August 3, 2023)]
[Notices]
[Page 51330]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-16575]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2023-N-2850]

Prescription Drug User Fee Rates for Fiscal Year 2024; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration is correcting a notice 
entitled ``Prescription Drug User Fee Rates for Fiscal Year 2024'' that 
appeared in the Federal Register of July 28, 2023. The document 
announced the rates for prescription drug user fees for fiscal year 
2024. The document was published with an incorrect value in a table. 
This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy, 
Legislation, and International Affairs, Food and Drug Administration, 
301-796-9115, [email protected].

SUPPLEMENTARY INFORMATION: In the Federal Register of July 28, 2023 (88 
FR 48881), in FR Doc. 2023-15911, the following correction is made:
    On page 48883, in section II.C., table 4, ``CDER Actual FY 2022 
Workload Volumes and Predicted FY 2024 Workload Volumes,'' in the third 
column (``FY 2024 predictions''), fourth row (``NDA/BLA Original''), 
``1,136'' is corrected to read ``136.''

    Dated: July 31, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-16575 Filed 8-2-23; 8:45 am]
BILLING CODE 4164-01-P